National Vaccine
Information Center

Your Health. Your Family. Your Choice.

MedAlerts Home
Search Results

This is VAERS ID 620270

Case Details

VAERS ID: 620270 (history)  
Form: Version 1.0  
Age: 14.0  
Gender: Female  
Location: Foreign  
Submitted: 2015-12-25
Entered: 2015-12-25
Vaccin­ation / Manu­facturer Lot / Dose Site / Route

Administered by: Other       Purchased by: Other
Symptoms: Abdominal pain, Arthralgia, Cognitive disorder, Dyspnoea, Fatigue, Headache, Muscle spasms, Muscular weakness, Palpitations, Postural orthostatic tachycardia syndrome, Sleep disorder, Syncope, Tilt table test positive
SMQs:, Torsade de pointes/QT prolongation (broad), Rhabdomyolysis/myopathy (broad), Anaphylactic reaction (broad), Acute pancreatitis (broad), Peripheral neuropathy (broad), Arrhythmia related investigations, signs and symptoms (broad), Retroperitoneal fibrosis (broad), Dementia (broad), Dystonia (broad), Acute central respiratory depression (broad), Pulmonary hypertension (broad), Guillain-Barre syndrome (broad), Noninfectious encephalitis (broad), Noninfectious encephalopathy/delirium (broad), Gastrointestinal nonspecific symptoms and therapeutic procedures (narrow), Cardiomyopathy (broad), Hypotonic-hyporesponsive episode (broad), Arthritis (broad), Hypoglycaemia (broad), Dehydration (broad)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? Yes
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: No other medications
Current Illness: HPV immunisation; Hepatitis A immunisation; Hepatitis B immunistion
Preexisting Conditions:
Diagnostic Lab Data: POTS during tilt table test
CDC Split Type: WAES1512DNK012324

Write-up: Information has been received from Sanofi Pasteur MSD (MFR number# DK-1577272925-2015001423) on 23-DEC-2015. Case received from a physician via health authority on 22-DEC-2015 under reference number DK-DKMA-WBS-0002135 and DK-DKMA-ADR 23278256. A 14-year-old female adolescent patient received GARDASIL, (batch number unknown , Dose 1) via intramuscular route on 06-OCT-2011, GARDASIL, (batch number unknown, Dose 2) via intramuscular route on 14-DEC-2011, GARDASIL, (batch number unknown, Dose 3) via intramuscular route on 02-MAY-2012. Other suspect products included Hepatitis A Virus, (batch number unknown) in 2014 Hepatitis B Virus, (batch number unknown) in 2014. The patient experienced Postural orthostatic tachycardia syndrome on an unknown date, Headache on an unknown date, Joint pain on an unknown date, Syncope on an unknown date, Palpitations on an unknown date, Abdominal pain on an unknown date, Dyspnea on an unknown date, Sleep disorder on an unknown date, Fatigue extreme on an unknown date, Cognitive disorder on an unknown date, Muscular spasm on an unknown date, muscular weakness on an unknown date and Subfebril on an unknown date. A bit uncertain regarding the timing of the progression HPV vaccinated 2011-2012 and hepatitis A abd B summer 2014. A bit uncertain if the symptoms started before the hepatitis vaccination, but at least the symptoms added/worsen the symptoms after hepatitis vaccination POTS with tilt table test: Criteria for POTS Heart rate increases greater than or equal to 30 bpm from supine to standing (10 min) in the absence of orthostatic hypotension (decrease in BP greater than 20/10 mmHg). Symptoms worsen with standing and improved with recumbence, Symptoms last greater than or equal to 6 months. Absence of other overt cause of orthostatic or tachycardia (e.g., active bleeding, acute dehydration, medications) In addition, the Hospital uses further criterion in patients between 12-19 years: requires a heart rate increase of greater than 40 bpm to make the diagnosis, the reasons for this is that young people have stronger physiological heart rate response when standing up. The additional criterion is used to avoid false positives. Other vaccines or medicines: unknown The patient''s outcome was reported as not recovered/not resolved.

New Search

Link To This Search Result:

Copyright © 2018 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166